Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new ...

Liver cancer might be on the rise as a silent epidemic. However, awareness coupled with cutting-edge treatments turn out to be a boon for the same. While Cutting-edge technology can offer ...

"This work will help us better understand liver cancer in Mexico and improve prevention, detection, and treatment strategies," he said. Melchor Ruan emphasized that this research was the result of ...

Alcoholic and non-alcoholic fatty liver disease (NAFLD) are well-known risk factors for colorectal cancer (CRC). NAFLD has ...

it could be an innovative approach to the prevention and treatment of liver cancer. It is unclear whether there are similar guardians in other organs. Moritz Mall and Judith Zaugg are convinced ...

Namodenoson is currently being evaluated in a pivotal Phase III trial for advanced liver cancer, a Phase IIb trial for the treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH), and in ...

In December, Detroit-based Barbara Ann Karmanos Cancer Center became the first facility in the world to offer at-home liver cancer treatment with the TheraBionic P1, a device recently approved by ...

Givosiran injected in patient suffering from rare condition affecting five in one million Dr Niyas Khalid of Burjeel Medical City with Muhammad who received innovative treatment for rare liver ...

Additionally, moderate ascites that were present before treatment have gradually resolved, with the patient now off diuretics for over a year. Liver stiffness, measured repeatedly during the ...

Even light drinking increases the risk, especially in those already treated for cancer. Alcohol consumption is traditionally associated with liver cirrhosis and liver cancer. However, a lesser ...

A phase 3 trial for myelofibrosis found that adding pelebresib to ruxolitinib was more effective than ruxolitinib alone and did not significantly increase side effects.